Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Unknown 3Completed 3Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 13Gastrointestinal 8Tumor-Agnostic 3Thoracic 3Other hematologic neoplasm 3Head & Neck 3Lymphoid 2Sarcoma 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Lung Neoplasms 2Prostatic Neoplasms 1Motor Activity 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 132Cisplatin 129Pemetrexed 114Docetaxel 81Drug Therapy 62Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 36Nivolumab 33Vinorelbine 31Radiosurgery 30sintilimab 29durvalumab 25aumolertinib 25endostar protein 24atezolizumab 22Endostatins 22toripalimab 19Blood Specimen Collection 19tislelizumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Control Groups × Thoracic × Clear all
NCT05319145 2022-04-13

PROFIT

Hospital Universitari Vall d'Hebron Research Institute

Phase NA Unknown
268 enrolled
GenitourinaryThoracic

Lung Neoplasms, Prostatic Neoplasms

NCT04105647 2020-04-28

Lifestyle Modification Program for Lung Cancer Patients - A Pilot Study

The University of Hong Kong

Phase NA Unknown
32 enrolled
Thoracic

Lung Neoplasms, Motor Activity

NCT00813332 2010-01-25

Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)

Simcere Pharmaceutical Co., Ltd

Phase 4 Unknown
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡